Alumis (ALMS) Change in Account Payables (2023 - 2025)
Alumis (ALMS) reported Change in Account Payables of $5.6 million for Q4 2025, up 74.31% year-over-year from $3.2 million in Q4 2024, and up 153.24% quarter-over-quarter from -$10.4 million in Q3 2025.
Alumis (ALMS) Change in Account Payables (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Change in Account Payables data on file, last reported at $5.6 million in Q4 2025.
- Change in Account Payables for Q4 2025 came in at $5.6 million, up 74.31% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.0 million (down 170.96% YoY), and the FY2025 annual result was -$6.0 million, down 170.96% from the prior year.
- Change in Account Payables improved to $5.6 million in Q4 2025 per ALMS's latest filing, from -$10.4 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $5.7 million in Q1 2024 and troughed at -$10.4 million in Q3 2025.
- A 3-year average of $116200.0 and a median of $1.5 million in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 196.87% in 2024, then slumped 322.71% in 2025.
- A 3-year view of Change in Account Payables shows it stood at -$3.3 million in 2023, then soared by 196.87% to $3.2 million in 2024, then surged by 74.31% to $5.6 million in 2025.
- Business Quant data shows ALMS's Change in Account Payables at $5.6 million in Q4 2025, -$10.4 million in Q3 2025, and $989000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 5.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | -10.42 Mn |
| Sep 30, 2025 | -10.42 Mn |
| Jun 30, 2025 | 989,000.00 |
| Jun 30, 2025 | 989,000.00 |
| Mar 31, 2025 | -2.15 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | -3.29 Mn |
| Dec 31, 2023 | -3.29 Mn |
| Sep 30, 2023 | 1.98 Mn |
| Sep 30, 2023 | 1.98 Mn |